Outset Halts Tablo Sales for Home Use Pending FDA Review of New Features
As Outset has added features improving Tablo since the FDA first cleared it for use, it has now had to submit another 510(k) application to the FDA, thus limiting sales to acute facilities only.
Read the full article » | Posted 07-13-2022
Related Articles
- The National Kidney Foundation has Updated Two of its Home Dialysis Resources Posted 03-13-2025
- See How Outset Medical is Bringing Home HD into Skilled Nursing Facilities Posted 03-13-2025
- Monogram Health Held a Home Dialysis Summit for its Clinicians Posted 03-13-2025
- Annual Dialysis Conference 2025 is in Las Vegas from 3/13-16/2025 Posted 03-13-2025